Suppr超能文献

自体腹膜移植物在腹部外科肿瘤切除后静脉血管重建中的应用:系统评价。

Autologous peritoneal graft for venous vascular reconstruction after tumor resection in abdominal surgery: a systematic review.

机构信息

HepatoBiliary and Pancreatic Surgery Unit, Department of Digestive and Endocrine Surgery, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Institut de Recherche Contre les Cancers de l'Appareil Digestif (IRCAD), IHU-Mix Surg, 1 place de l'Hôpital, 67091, Strasbourg, France.

出版信息

Updates Surg. 2020 Sep;72(3):605-615. doi: 10.1007/s13304-020-00730-9. Epub 2020 Mar 6.

Abstract

Radical surgical resection (R0) is the only option to cure patients with borderline resectable or multivisceral intraabdominal malignancies involving major vessels. Autologous peritoneal flap has been described as a safe and versatile option for vascular reconstruction, but still limited experience exists regarding its use. An extensive literature review was performed to analyze results of vascular reconstruction with an autologous peritoneal graft. Fifteen reports were found for a total of 94 patients. No cases of arterial vascular reconstruction were found. Two different types of peritoneal patch have been described, backed (APFG, 30 patients) or not backed (ANFP, 64 patients) by posterior rectus sheath. A patch type of reconstruction was adopted in 70 patients (74.5%), while a tubular reconstruction in 24 (25.5%). Postoperative mortality was 5.3% (5 cases). Graft outcomes with very heterogeneous follow-ups (7 days-47 months) were available only in 85 patients (90.4%). Among them, a graft patency was documented in 80 patients (94.1%), while a stenotic graft was reported in 5 patients (5.9%). No differences in graft outcomes were observed between the patch and tubular groups (p = 0.103), nor between the ANFP and APFG groups (p = 0.625). In reported experiences, autologous peritoneal graft seems to represent a safe and versatile option for functional restoration of venous vascular anatomy after resection, especially in operations with high risk of contamination, trauma, liver transplantation and unplanned vascular resection. Unfortunately, the data available in the literature do not make it possible to draw any evidence-based conclusions on these considerations.

摘要

根治性手术切除(R0)是治疗涉及主要血管的边界可切除或多内脏腹腔恶性肿瘤患者的唯一选择。自体腹膜瓣已被描述为血管重建的安全且多功能的选择,但关于其使用的经验仍然有限。进行了广泛的文献复习,以分析使用自体腹膜移植物进行血管重建的结果。共发现 15 份报告,涉及 94 例患者。未发现动脉血管重建的病例。已经描述了两种不同类型的腹膜补片,一种是有后腹壁直肌鞘支撑的(APFG,30 例),另一种是没有支撑的(ANFP,64 例)。70 例患者(74.5%)采用补片式重建,24 例患者(25.5%)采用管状重建。术后死亡率为 5.3%(5 例)。只有 85 例患者(90.4%)的移植结果具有非常异质的随访(7 天-47 个月)。在这些患者中,80 例(94.1%)记录到移植物通畅,5 例(5.9%)报告移植物狭窄。在补片组和管状组之间(p = 0.103)以及在 ANFP 组和 APFG 组之间(p = 0.625),均未观察到移植结果的差异。在报告的经验中,自体腹膜瓣似乎是一种安全且多功能的选择,可用于切除后静脉血管解剖的功能恢复,尤其是在污染、创伤、肝移植和计划外血管切除风险较高的手术中。不幸的是,文献中可用的数据无法对这些考虑因素得出任何循证结论。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验